John D. Varigos

553 St. Kilda Rd
Melbourne, VIC 3004, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial.

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: January 07, 2022

Risk stratification of cardiovascular complications using CHA2DS2-VASc and CHADS2 scores in chronic atherosclerotic cardiovascular disease.

Risk stratification of cardiovascular complications using CHA2DS2-VASc and CHADS2 scores in chronic atherosclerotic cardiovascular disease.

Journal: International journal of cardiology

Published: December 29, 2020

Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy.

Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy.

Journal: Stroke

Published: September 21, 2020

Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants.

Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants.

Journal: European heart journal

Published: June 12, 2020

Stroke Outcomes in the COMPASS Trial.

Stroke Outcomes in the COMPASS Trial.

Journal: Circulation

Published: January 23, 2019

Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial.

Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: July 31, 2018

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.

Journal: Lancet (London, England)

Published: July 17, 2017

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.

Journal: Lancet (London, England)

Published: July 17, 2017

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.

Journal: The Canadian journal of cardiology

Published: May 25, 2017

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.

Journal: The New England journal of medicine

Published: April 05, 2016

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Journal: The New England journal of medicine

Published: April 05, 2016

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Journal: The New England journal of medicine

Published: April 05, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026